27.08.2023 Views

[Rice Catalyst Issue 14]

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Comparing Electrode and<br />

Optogenetic Solutions<br />

for Artificial Sight<br />

KATHERINE WU<br />

ABSTRACT<br />

Electrode-based systems and optogenetics<br />

are two distinct methods that address<br />

blindness by developing artificial vision.<br />

Optogenetics is a rapidly evolving field that<br />

involves the use of light to control the activity<br />

of cells in living tissue, typically neurons.<br />

Some current areas of research include<br />

designing smaller and more efficient<br />

optogenetic devices, developing new ways<br />

to target specific cell types, and using optogenetics<br />

to study and treat a wider range of<br />

brain disorders. By comparison, electrode-based<br />

solutions for restoring vision<br />

involve implanting an array of electrodes<br />

to bypass a damaged retina and stimulate<br />

remaining cells in the visual pathway, allowing<br />

people with certain retinal diseases to<br />

regain some level of visual perception. This<br />

review discusses the effectiveness of both<br />

electrodes and optogenetics in producing<br />

artificial vision.<br />

INTRODUCTION<br />

Vision loss can have a profound impact on<br />

an individual’s quality of life, affecting their<br />

ability to engage in daily activities, maintain<br />

independence, and participate in society.<br />

Aging populations around the world are<br />

beginning to experience greater rates of<br />

age-related vision reduction, presenting<br />

as macular degeneration, glaucoma, and<br />

cataracts. Although an important public<br />

health issue, the issue at hand necessitates<br />

costly assistive devices and long-term<br />

care. Therefore, continued research and<br />

development in technologies to restore<br />

and improve vision is an important area for<br />

future investment.<br />

OPTOGENETIC SOLUTIONS<br />

Optogenetics is a technique that uses light<br />

to control and study the activity of cells<br />

Optogenetics is a technique<br />

that uses light to control and<br />

study the activity of cells in<br />

the brain and other tissues,<br />

allowing researchers to better<br />

understand and potentially<br />

treat neurological disorders.<br />

in the brain and other tissues, allowing<br />

researchers to better understand and<br />

potentially treat neurological disorders.<br />

Optogenetics uses a genetic tool called<br />

the LoxP system to selectively control the<br />

expression of specific genes in cells. LoxP<br />

is a specific DNA sequence recognized by<br />

a protein called Cre recombinase, which is<br />

commonly used to manipulate the expression<br />

of genes in cells. Cell genomes can be<br />

edited by light-activated enzymes called Cre<br />

recombinases that localize to flanking LoxP<br />

sites at specific locations to either activate<br />

or silence gene expression in a precise and<br />

reversible manner. By selectively activating<br />

or silencing gene expression optogenetics<br />

can achieve gain-of-function or loss-of-function<br />

of specific cells of living tissue [1].<br />

Optogenetics uses light to control specific<br />

neurons by introducing a protein into the<br />

neurons that responds to light; when light<br />

is shone on these neurons, the protein activates<br />

or deactivates the neuron, allowing<br />

researchers to study the effects of specific<br />

neural activity on behavior or physiology. In<br />

optogenetics, two proteins are commonly<br />

introduced into neurons. The first are opsins.<br />

Opsins are light-sensitive proteins that<br />

respond to different wavelengths of light,<br />

and they can be used to activate or inhibit<br />

neural activity depending on the type of<br />

opsin used. The second protein is enzymes.<br />

Enzymes are proteins that can be activated<br />

by light to perform specific chemical reactions,<br />

and they can be used to manipulate<br />

various signaling pathways or biochemical<br />

processes within neurons. By introducing<br />

these proteins into neurons, researchers<br />

can control the activity of the neurons with<br />

light, allowing them to better understand<br />

how neural activity contributes to behavior<br />

and disease [Figure 1].<br />

Manipulating gene expression of specific<br />

cells using proteins and light allows<br />

individuals to experience a phosphene,<br />

which is a sensation of light without any<br />

light actually entering their eyes. These<br />

FIGURE 1: Shining intense red (635nm) light<br />

opens the rhodopsin, allowing ions to flow<br />

into the neuron. The result is neuronal<br />

activation and specific behavior. In optogenetics,<br />

rhodopsins are used to activate<br />

neurons by allowing the influx of positively<br />

charged ions into the cell in response to<br />

light. This causes the neuron to depolarize<br />

and fire an action potential, allowing<br />

researchers to control the activity of the<br />

neuron with light.<br />

2022-2023 C A T A L Y S T | 2 5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!